Chronic hepatitis B (CHB) poses a huge health care burden as it is a common cause of chronic liver disease and is also associated with the development of liver cirrhosis and liver cancer. The ...

Despite the standard immunoprophylaxis, a significant portion of infants born to highly viremic mothers remain infected with hepatitis B virus (HBV). Emerging data suggest that antiviral therapy ...

Chronic hepatitis B (CHB) is currently estimated to affect over 250 million people worldwide, and tenofovir disoproxil fumarate (TDF) is currently the most widely used antiviral agent for CHB ...

The following is a summary of “Chronic hepatitis B virus infection increases the risk of kidney disease while antiviral ...

The federal Health Department is proposing universal testing to ensure everyone knows their hepatitis B status, amid concerns ...

While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the body's defences are unable to ...

Catching HBV early can make a world of difference. Medical professionals typically use blood tests that check for signs of ...

Scientists from the Institut Pasteur, in collaboration with Kumamoto University in Japan, have assessed a new rapid diagnostic test to identify pregnant women at elevated risk of transmitting ...

Interferon Abbreviations: FDA, U.S. Food and Drug Administration; HBV, hepatitis B virus. 1 Division of Gastroenterology and Hepatology, Department of Medicine, NYU Langone Medical Center ...